Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study
Dayan, Colin M.
JAMA Internal Medicine
American Medical Association
Copyright 2014 American Medical Association
Reason for embargo
Rates of thyroid hormone prescribing in the United States and the United Kingdom have increased substantially. If some of the increase is due to lowering the thyrotropin threshold for treatment, this may result in less benefit and greater harm.
Medical Research Council
This is the author's post-print version of the article, which has been published in final form in JAMA Internal Medicine, and can be accessed via the DOI in this record.
JAMA Internal Medicine, 2014, vol. 174, issue 1, pp. 32 - 39
Place of publication